We maintain BUY on Hong Leong Bank (HLBB) with unchanged fair value ofRM22.60/share based on FY24F ROE of 11.2%, leading to a P/BV of 1.2x. No change to our 4-star ESG rating, which we have accorded a 3% premium to the valuation.
We tweaked our FY26F earnings slightly by 1.2% to reflect a higher non-interest income (NOII) estimate.
We attended HLBB’s investor day yesterday which provided details on the group’s transformation plan for the next 3-5 years.
The group aspires to be the top-3 in terms of the bestmanaged bank domestically in the next 3-5 years.
HLBB targets a ROE of 12-12.5% within the next 2 years (FY24-FY25) from 11.8% in FY23 and thereafter ROE > 12.5% from FY26 onwards. Aside from ROE, it is aiming for a CI ratio of 40%, credit cost of 10bps, CASA mix of 35% and non-interest income (NOII) to total income ratio of >25% (Exhibit: 1).
Management alluded to opportunities to uplift the group’s ROE in the next 3-5 years from (Exhibit 2): i. Accelerating loan growth in targeted portfolios. This includes expansion in SME and overseas loans; ii. Increase in contribution from capital light businesses such as forex, hedging solutions, wealth management, trade -related fees and other fee income under its business & corporate banking (BCB) segment. We understand that NOII will contribute 45-50% of the incremental uplift in ROE targeted and iii. Higher PBT contribution from regional operations (mainly Singapore) from 2.2% in FY23 to 7% by FY28.
As of end FY23, HLBB’s loans comprised of 62% retail, 17% SME, 13% business and corporate banking and 8% international loans (largely Singapore, followed by Cambodia and Vietnam). Management alluded to a potential shift in loan mix by FY2028 (Year 5) towards 50:50 retail/business loans. This will be through a gradual lowering of the share in retail loans and a higher mix of SME and overseas loans (Exhibit 4). The initiative will see the group leaning towards higher quality borrowers for business loans, hence a sacrifice on NIM as lending rates are likely to be more competitive.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....